Pauline Evers

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 322 citations · Full text

Medicine, Oncology, Surgery +16

Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial

Charlotte E.L. Klaver, Gijsbert D. Musters, Willem A. Bemelman et al. · BMC Cancer · 2015 · 133 citations · Full text

Medicine, Oncology, Surgery +17

Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma

Peter Palmer, Jan Vinke, Pauline Evers et al. · European Journal of Cancer · 1992 · 63 citations

Life Sciences, Immunology, Oncology +12

Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study.

Jens Atzpodien, Alfred Körfer, Pauline Evers et al. · PubMed · 1990 · 62 citations

Medicine, Oncology, Pharmacology +17

A Comparison of 2 Modes of Administration of Recombinant Interleukin-2: Continuous Intravenous Infusion Alone Versus Subcutaneous Administration plus Interferon Alpha in Patients with Advanced Renal Cell Carcinoma.

Peter Palmer, Jens Atzpodien, Thierry Philip et al. · Cancer Biotherapy · 1993 · 55 citations

Medicine, Oncology, Pharmacotherapy +13